Synovics Pharmaceuticals Company Description
Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States.
The company’s OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives.
It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States.
The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006.
Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.
| Country | United States |
| Founded | 1983 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 155 |
| CEO | Jyotindra Gange |
Contact Details
Address: 5360 Northwest 35th Avenue Fort Lauderdale, Florida 33309 United States | |
| Phone | 954-486-4590 |
Stock Details
| Ticker Symbol | SYVC |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | November - October |
| Reporting Currency | USD |
| ISIN Number | US87163M1018 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| John R. Palmer | Chairman of InCon Technologies Inc.& Incon International Ltd. and Chief Executive Officer of InCon Technologies Inc |
| Jyotindra R. Gange | Interim Principal Executive Officer and Director |